{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:41:57Z","timestamp":1792010517740,"version":"4.4.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec040\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>The Notch pathway plays an important role in many aspects of cancer biology and acts in a dichotomous way in bladder cancer. The mechanisms behind this behavior are still elusive. Here, we analyzed DLL4 and Notch receptor expression, interaction and downstream signaling in human bladder cancer cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec041\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>The expression levels of Notch pathway components (Notch1-4, DLL4, HES1, HEY1) were assessed in papillary (G1: RT-4) and non-papillary bladder cancer cell lines (G2-G4: RT-112, 647-V, T-24, KU-19-19, CAL-29) by qRT-PCR and immunofluorescence. Expression data were validated by analyzing data from open-source databases (CCLE; TCGA). The endogeneous interactions of Notch2\/Notch3 receptors and the ligand DLL4 were studied by in situ proximity ligation assay. Activation of canonical Notch signaling was evaluated by stimulation with recombinant DLL4 protein.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec042\">\n<jats:title>Results<\/jats:title>\n<jats:p>All Notch targets were expressed, with Notch2 and Notch3 showing the highest expression levels. Endogeneous interactions between Notch2\/3 and DLL4 were detected in all BCa cell lines. Amounts of Notch2\/3-DLL4 complexes were high in RT-112 and CAL-29, while RT-4\/647-V showed moderate and T-24, KU-19-19 low abundance. Proportion of (peri-) nuclear interaction complexes correlated negatively with Notch downstream targets. DLL4 stimulation resulted in canonical Notch pathway activation and increased tumor cell viability and proliferation in RT-4, 647-V, T-24 and KU-19-19 cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec043\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>The Notch signaling pathway can discriminate between different receptors and may play an essential role in the progression of bladder carcinoma. We demonstrated for the first time direct interactions between DLL4 and Notch2\/3 associated to activation of canonical downstream Notch signaling and increased tumor cell behavior in human bladder cancer cells. Our data support the view that the Notch2\/3-DLL4 axis plays an oncogenic role in bladder cancer. Further analyses of Notch signaling in bladder cancer can promote the development of tailored anti-DLL4\/Notch bladder cancer therapies in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0317709","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:36:12Z","timestamp":1739558172000},"page":"e0317709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Notch2\/3-DLL4 interaction in urothelial cancer cell lines supports a tumorigenic role of Notch signaling pathways in bladder carcinoma"],"prefix":"10.1371","volume":"20","author":[{"given":"Chuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Weimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Uwe","family":"Stolzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-2693","authenticated-orcid":true,"given":"Mandy","family":"Berndt-Paetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"pone.0317709.ref001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-397927-8.00007-5","article-title":"Targeting Notch signaling for cancer therapeutic intervention","volume":"65","author":"H Shao","year":"2012","journal-title":"Adv Pharmacol"},{"issue":"7104","key":"pone.0317709.ref002","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nature04940","article-title":"Notch signalling regulates stem cell numbers in vitro and in vivo","volume":"442","author":"A Androutsellis-Theotokis","year":"2006","journal-title":"Nature"},{"issue":"10","key":"pone.0317709.ref003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12032-017-1039-6","article-title":"Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy","volume":"34","author":"L Li","year":"2017","journal-title":"Med Oncol"},{"key":"pone.0317709.ref004","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fonc.2018.00518","article-title":"Moving breast cancer therapy up a Notch","volume":"8","author":"EWJ Mollen","year":"2018","journal-title":"Front Oncol"},{"key":"pone.0317709.ref005","first-page":"8707053","article-title":"Notch signaling activation as a hallmark for triple-negative breast cancer subtype","author":"MV Giuli","year":"2019","journal-title":"J Oncol"},{"key":"pone.0317709.ref006","doi-asserted-by":"crossref","first-page":"15330338221118984","DOI":"10.1177\/15330338221118984","article-title":"Expressions and prognostic values of Notch3 and DLL4 in human breast cancer","volume":"22","author":"L Wang","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"pone.0317709.ref007","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fonc.2018.00267","article-title":"Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?","volume":"8","author":"V Sosa Iglesias","year":"2018","journal-title":"Front Oncol"},{"issue":"6","key":"pone.0317709.ref008","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/cells9061549","article-title":"A review on Notch signaling and colorectal cancer","volume":"9","author":"A Tyagi","year":"2020","journal-title":"Cells"},{"issue":"3","key":"pone.0317709.ref009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/CBM-200986","article-title":"Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome","volume":"33","author":"Z Zhang","year":"2022","journal-title":"Cancer Biomark"},{"issue":"1","key":"pone.0317709.ref010","first-page":"53","article-title":"Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma","volume":"16","author":"H-Y Song","year":"2018","journal-title":"Exp Ther Med"},{"issue":"21","key":"pone.0317709.ref011","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1074\/jbc.RA118.006983","article-title":"NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells","volume":"294","author":"E Farah","year":"2019","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0317709.ref012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","article-title":"Targeting Notch in oncology: the path forward","volume":"20","author":"S Majumder","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"pone.0317709.ref013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41585-018-0005-1","article-title":"Unravelling disparate roles of NOTCH in bladder cancer","volume":"15","author":"A Goriki","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"2","key":"pone.0317709.ref014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"R Kopan","year":"2009","journal-title":"Cell"},{"issue":"17","key":"pone.0317709.ref015","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00018-010-0391-x","article-title":"Non-canonical activation of Notch signaling\/target genes in vertebrates","volume":"67","author":"R Sanalkumar","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"pone.0317709.ref016","first-page":"1249","article-title":"Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition","volume":"6","author":"I Espinoza","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"7684","key":"pone.0317709.ref017","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature24998","article-title":"A non-canonical Notch complex regulates adherens junctions and vascular barrier function","volume":"552","author":"WJ Polacheck","year":"2017","journal-title":"Nature"},{"key":"pone.0317709.ref018","first-page":"151","article-title":"Notch2 and immune function","volume":"360","author":"M Sakata-Yanagimoto","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"pone.0317709.ref019","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3678","article-title":"A new tumor suppressor role for the Notch pathway in bladder cancer","volume":"20","author":"T Rampias","year":"2014","journal-title":"Nat Med"},{"issue":"12","key":"pone.0317709.ref020","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1158\/1078-0432.CCR-15-2360","article-title":"Not all NOTCH is created equal: The oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy","volume":"22","author":"T Hayashi","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"21","key":"pone.0317709.ref021","doi-asserted-by":"crossref","first-page":"34362","DOI":"10.18632\/oncotarget.16156","article-title":"Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma","volume":"8","author":"H Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"pone.0317709.ref022","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1158\/1078-0432.CCR-06-0285","article-title":"Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer","volume":"12","author":"NS Patel","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"pone.0317709.ref023","doi-asserted-by":"crossref","first-page":"869-880.e19","DOI":"10.1016\/j.cell.2018.01.002","article-title":"Dynamic ligand discrimination in the notch signaling pathway","volume":"172","author":"N Nandagopal","year":"2018","journal-title":"Cell"},{"issue":"12","key":"pone.0317709.ref024","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/cancers13123089","article-title":"A comprehensive bioinformatics analysis of Notch pathways in bladder cancer","volume":"13","author":"C Zhang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"pone.0317709.ref025","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"J Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"21","key":"pone.0317709.ref026","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.3390\/ijms222112057","article-title":"Immunocytochemical analysis of endogenous Frizzled-(Co-)receptor interactions and rapid Wnt pathway activation in mammalian cells","volume":"22","author":"J Neuhaus","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0317709.ref027","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"O Meurette","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"pone.0317709.ref028","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/0008-5472.CAN-08-2791","article-title":"Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy","volume":"69","author":"S Indraccolo","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0317709.ref029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccr.2010.11.008","article-title":"Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling","volume":"19","author":"M Sonoshita","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"pone.0317709.ref030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"MC Boelens","year":"2014","journal-title":"Cell"},{"issue":"7654","key":"pone.0317709.ref031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature22323","article-title":"Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer","volume":"545","author":"JS Lim","year":"2017","journal-title":"Nature"},{"key":"pone.0317709.ref032","doi-asserted-by":"crossref","first-page":"e37880","DOI":"10.7554\/eLife.37880","article-title":"Cis-activation in the Notch signaling pathway","volume":"8","author":"N Nandagopal","year":"2019","journal-title":"Elife"},{"issue":"10","key":"pone.0317709.ref033","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/cells9102212","article-title":"Targeting Notch Trafficking and Processing in Cancers","volume":"9","author":"L Pagliaro","year":"2020","journal-title":"Cells"},{"issue":"1","key":"pone.0317709.ref034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s42003-022-03013-8","article-title":"Two distinct Notch signals, Delta-like 4\/Notch1 and Jagged-1\/Notch2, antagonistically regulate chemical hepatocarcinogenesis in mice","volume":"5","author":"Y Nakano","year":"2022","journal-title":"Commun Biol"},{"issue":"3","key":"pone.0317709.ref035","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s13277-015-4202-8","article-title":"The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study","volume":"37","author":"J-F Zhang","year":"2016","journal-title":"Tumour Biol"},{"issue":"1","key":"pone.0317709.ref036","doi-asserted-by":"crossref","first-page":"e171821","DOI":"10.1172\/jci.insight.171821","article-title":"DLL4\/Notch3\/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells","volume":"9","author":"S Alve","year":"2024","journal-title":"JCI Insight"},{"issue":"6","key":"pone.0317709.ref037","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1096\/fj.201902659R","article-title":"CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2\/HEY1 signaling","volume":"34","author":"Z Zhou","year":"2020","journal-title":"FASEB J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:36:24Z","timestamp":1739558184000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317709"}},"subtitle":[],"editor":[{"given":"Abhinava Kumar","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}